Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?

John Abraham; Rachel Ballinger

首页> 外文期刊>Journal of community genetics >Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?

【24h】

Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?

机译：权力，专业知识和代议制民主的局限性：遗传学是药物致癌风险评估中的科学进步还是政治合法性？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of community genetics》 |2012年第2期|共13页
作者
John Abraham; Rachel Ballinger;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类遗传学;
关键词
入库时间 2022-08-18 16:21:35

相似文献

外文文献
中文文献
专利

1. Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals? [J] . John Abraham, Rachel Ballinger Journal of Community Genetics . 2012,第2期

机译：权力，专业知识和代议制民主的局限：遗传学是药物致癌风险评估中的科学进步还是政治合法性？
2. The emergence of the genetically engineered animal models in carcinogenic risk assessment of pharmaceuticals: a case study of process innovation [J] . Abraham John, Ballinger Rachel New Genetics and Society . 2012,第2期

机译：基因工程动物模型在药物致癌风险评估中的出现：工艺创新案例研究
3. The emergence of the genetically engineered animal models in carcinogenic risk assessment of pharmaceuticals: a case study of process innovation [J] . JohnAbrahama*RachelBallingerb New Genetics and Society . 2012,第2期

机译：基因工程动物模型在药物致癌风险评估中的出现：工艺创新案例研究
4. The Risk Assessment of the Economic Interests of the Arctic and the Political Power Game Based on the Cloud Model [C] . Mengqian Yang, Shanshan Ge, Ren Zhang, Annual Meeting of Risk Analysis Committee of China Association for Disaster Prevention . 2016

机译：基于云模型的北极和政治权力博弈的风险评估
5. Power expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals? [O] . John Abraham, Rachel Ballinger 2012

机译：权力专业知识和代议制民主的局限：遗传学是药物致癌风险评估中的科学进步还是政治合法性？
6. Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals? [O] . Abraham, John, Ballinger, Rachel 2011

机译：权力，专业知识和代议制民主的局限：遗传学是药物致癌风险评估中的科学进步还是政治合法性？
7. M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk: Guidance for Industry. [R] . 2015

机译：m7评估和控制药物中DNa反应性（致突变性）杂质以限制潜在的致癌风险：工业指南。

Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?

著录项

相似文献

相关主题

期刊订阅